STAT3 and prostate carcinoma: Based on our results, CDK5 activation promotes the growth of prostate cancer cells by direct interaction with STAT3 through Ser-727 phosphorylation, while CDK5-mediated STAT3 activation contributes to full AR transactivation in addition to CDK5-dependent Ser81-AR regulation, as described previously.